相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vitiligo: Mechanisms of Pathogenesis and Treatment
Michael L. Frisoli et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade
Shinsuke Nakao et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Cellular cytotoxicity is a form of immunogenic cell death
Luna Minute et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania
Zacchaeus Anywaine et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Lymph node conduits transport virions for rapid T cell activation
Glennys V. Reynoso et al.
NATURE IMMUNOLOGY (2019)
Oncolytic viruses: how lytic must they be for therapeutic efficacy?
Maria Eugenia Davola et al.
ONCOIMMUNOLOGY (2019)
A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules
Margaret E. Gatti-Mays et al.
CLINICAL CANCER RESEARCH (2019)
Tumor-Localized Costimulatory T-Cell Engagement by the 4-1BB/HER2 Bispecific Antibody-Anticalin Fusion PRS-343
Marlon J. Hinner et al.
CLINICAL CANCER RESEARCH (2019)
Optimization of 4-1BB antibody for cancer immunotherapy by balancing agonistic strength with FcγR affinity
Xinyue Qi et al.
NATURE COMMUNICATIONS (2019)
Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen
Stefanie K. Wculek et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy
Christina Claus et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox
Phillip R. Pittman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies
Jose Medina-Echeverz et al.
NATURE COMMUNICATIONS (2019)
Transposable element expression in tumors is associated with immune infiltration and increased antigenicity
Yu Kong et al.
NATURE COMMUNICATIONS (2019)
Tissue-resident memory CD8+ T cells promote melanoma-immune equilibrium in skin
Simone L. Park et al.
NATURE (2019)
Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines
Stephen J. Russell et al.
CANCER CELL (2018)
Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27-Dependent Pathway
Todd Bartkowiak et al.
CLINICAL CANCER RESEARCH (2018)
T Cells in Nonlymphoid Tissues Give Rise to Lymph-Node-Resident Memory T Cells
Lalit K. Beura et al.
IMMUNITY (2018)
The function and dysfunction of memory CD8+ T cells in tumor immunity
James L. Reading et al.
IMMUNOLOGICAL REVIEWS (2018)
Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial
Edgar Turner Overton et al.
PLOS ONE (2018)
Human endogenous retroviruses and their implication for immunotherapeutics of cancer
A. S. Attermann et al.
ANNALS OF ONCOLOGY (2018)
Integrating oncolytic viruses in combination cancer immunotherapy
Praveen K. Bommareddy et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
Peter Ellmark et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
Neil H. Segal et al.
CLINICAL CANCER RESEARCH (2017)
Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally
M. Angela Aznar et al.
JOURNAL OF IMMUNOLOGY (2017)
Intrinsic 4-1BB signals are indispensable for the establishment of an influenza-specific tissue-resident memory CD8 T-cell population in the lung
A. C. Zhou et al.
MUCOSAL IMMUNOLOGY (2017)
Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells
Michel Enamorado et al.
NATURE COMMUNICATIONS (2017)
Induction of resident memory T cells enhances the efficacy of cancer vaccine
Mevyn Nizard et al.
NATURE COMMUNICATIONS (2017)
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient
Alejandro Jimenez-Sanchez et al.
CELL (2017)
Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells
Peihong Dai et al.
SCIENCE IMMUNOLOGY (2017)
Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy
Alfonso R. Sanchez-Paulete et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Immune responses to endogenous retroelements: taking the bad with the good
George Kassiotis et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
4-1 BB agonists: multi-potent potentiators of tumor immunity
Todd Bartkowiak et al.
FRONTIERS IN ONCOLOGY (2015)
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
Alena Gros et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Cutting Edge: Resident Memory CD8 T Cells Occupy Frontline Niches in Secondary Lymphoid Organs
Jason M. Schenkel et al.
JOURNAL OF IMMUNOLOGY (2014)
Locally Delivered CD40 Agonist Antibody Accumulates in Secondary Lymphoid Organs and Eradicates Experimental Disseminated Bladder Cancer
Linda C. Sandin et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion
Dimitra Peppa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Genetic adjuvantation of recombinant MVA with CD40L potentiates CD8T cell meciated immunity
Henning Lauterbach et al.
FRONTIERS IN IMMUNOLOGY (2013)
Murine leukemia virus envelope gp70 is a shared biomarker for the high-sensitivity quantification of murine tumor burden
Francesca Scrimieri et al.
ONCOIMMUNOLOGY (2013)
Subcapsular sinus macrophages promote NK cell accumulation and activation in response to lymph-borne viral particles
Zacarias Garcia et al.
BLOOD (2012)
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Seng-Ryong Woo et al.
CANCER RESEARCH (2012)
Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity
Philipp A. Lang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The HIF-1α Hypoxia Response in Tumor-Infiltrating T Lymphocytes Induces Functional CD137 (4-1BB) for Immunotherapy
Asis Palazon et al.
CANCER DISCOVERY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1
B. Huang et al.
GENE THERAPY (2011)
Immune Requirements of Post-Exposure Immunization with Modified Vaccinia Ankara of Lethally Infected Mice
Henning Lauterbach et al.
PLOS ONE (2010)
Immune regulation by 4-1BB and 4-1BBL: complexities and challenges
Chao Wang et al.
IMMUNOLOGICAL REVIEWS (2009)
Vaccinia Virus-Mediated Inhibition of Type I Interferon Responses Is a Multifactorial Process Involving the Soluble Type I Interferon Receptor B18 and Intracellular Components
Zoe Waibler et al.
JOURNAL OF VIROLOGY (2009)
Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain
Mark Suter et al.
VACCINE (2009)
Lnterleukin-15/interieukin-15Rα complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells
Mathieu Epardaud et al.
CANCER RESEARCH (2008)
Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection
Christofer Samuelsson et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Age-dependent tolerance to an endogenous tumor-associated antigen
Jennifer A. McWilliams et al.
VACCINE (2008)
Mechanisms involved in synergistic anticancer immunity of Anti-4-1BB and Anti-CD4 therapy
Beom K. Choi et al.
CANCER RESEARCH (2007)
Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells
SM Kaech et al.
NATURE IMMUNOLOGY (2003)
Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment
EJ Wherry et al.
JOURNAL OF VIROLOGY (2003)
HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function
V Appay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
